| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
The Cover
Intracerebral microinfusion dramatically improves delivery of trastuzumab to the brain. 125I-radiolabeled trastuzumab was quantitated in the brain by autoradiography. After intraperitoneal delivery, trastuzumab was not detected intracerebrally. In contrast, after intracerebral microinfusion, trastuzumab saturated the entire cerebral hemisphere (P = 0.013). For details, see P. Grossi et al. in this issue.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |